Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intrapericardial therapy and diagnosis.

Literature DB >> 11743918

Intrapericardial therapy and diagnosis.

Abstract

Diagnosis and treatment for the heart and virtually all its structures is becoming available via the pericardium. With or without pericardial effusion (formerly necessary for safe access), instruments that can enter the noneffusive pericardium are available and thoroughly tested experimentally, with human trials currently under way. Successful therapy includes antiarrhythmic, vasodilatory, angiogenic, and other gene-related modalities and agents that stimulate the pericardial mesothelium to exceed the normal production of many active substances.

Entities: Disease Species

Mesh：

Year: 2002 PMID： 11743918 DOI： 10.1007/s11886-002-0122-5

Source DB: PubMed Journal: Curr Cardiol Rep ISSN： 1523-3782 Impact factor: 2.931

26 in total

1. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia.

Authors: E Sosa; M Scanavacca; A D'Avila; J Piccioni; O Sanchez; J L Velarde; M Silva; B Reolão
Journal: J Cardiovasc Electrophysiol Date: 1998-03

2. Transatrial access to the normal pericardial space: a novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions.

Authors: R L Verrier; S Waxman; E G Lovett; R Moreno
Journal: Circulation Date: 1998-11-24 Impact factor: 29.690

3. Minimally invasive access of the normal pericardium: initial clinical experience with a novel device.

Authors: M P Macris; S R Igo
Journal: Clin Cardiol Date: 1999-01 Impact factor: 2.882

4. Iatrogenic Cushing's syndrome after intrapericardial corticosteroid therapy.

Authors: S R Grubb; L K Cantley; D L Jones; W H Carter
Journal: Ann Intern Med Date: 1981-12 Impact factor: 25.391

5. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries.

Authors: S Kinlay; D Behrendt; M Wainstein; J Beltrame; J C Fang; M A Creager; A P Selwyn; P Ganz
Journal: Circulation Date: 2001-09-04 Impact factor: 29.690

6. Myocardial temperature reduction attenuates necrosis after prolonged ischemia in rabbits.

Authors: S L Hale; R A Kloner
Journal: Cardiovasc Res Date: 1998-12 Impact factor: 10.787

7. The pericardium as a source of prostacyclin in the dog, ox and rat.

Authors: R D Nolan; G J Dusting; J Jakubowski; T J Martin
Journal: Prostaglandins Date: 1982-12

8. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.

Authors: J T Willerson; S R Igo; S K Yao; J C Ober; M P Macris; J J Ferguson
Journal: Tex Heart Inst J Date: 1996

9. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia.

Authors: C Landau; A K Jacobs; C C Haudenschild
Journal: Am Heart J Date: 1995-05 Impact factor: 4.749

10. "Normothermic range" temperature affects myocardial infarct size.

Authors: G L Chien; R A Wolff; R F Davis; D M van Winkle
Journal: Cardiovasc Res Date: 1994-07 Impact factor: 10.787

1 in total

1. Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention.

Authors: Victor Segura-Ibarra; Francisca E Cara; Suhong Wu; David A Iruegas-Nunez; Sufen Wang; Mauro Ferrari; Arturas Ziemys; Miguel Valderrabano; Elvin Blanco
Journal: J Control Release Date: 2017-07-09 Impact factor: 9.776

1 in total